Presented by: Oyeyemi Ajayi, Prashant Kuntala, and Colin Kruse

Slides:



Advertisements
Similar presentations
An introduction to CRISPR gene engineering
Advertisements

Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:
Genetic Engineering: Some Basic Concepts. DNA: The Information Carrier.
DNA Repair Types Direct repair Excision repair Recombination repair
“CRISPR genome editing” Precise gene regulation/modification using the simple CRISPR/Cas9 system Thank you. Nucleeases will be used as a new tool that.
1 Jin-Soo Kim Dept. of Chemistry, Seoul National Univ. Center for Genome Engineering, Institute for Basic Science Genome Editing: Challenges and Opportunities.
Gene editing: From biblical times to the present
DNA Repair DNA repair is a system used to correct DNA damage caused by either: 1-Errors during DNA replication including incorrect base-pairing (mismatching)
AID Phosphorylation By 杨潇 李毅捷 Background Introduction  B cells undergo two types of genomic alterations to increase antibody diversity: somatic.
DNA Repair DNA repair is a system used to correct DNA damage caused by either: A- Errors during DNA replication including incorrect base-pairing (mismatching.
Maimona Saeed Ph. D Scholar Department of Botany
Depurination Release of adenine or guanine bases.
Genome Editing by Matthew Porteus Department of Pediatrics,
WORKSHOP: CRISPR in insects
DNA damage and repair summary
Genome editing to breed better plants
Variation Mutations DNA repair
CRISPR and Targeted Genome Editing
Genome Editing AGRY 600 Fall 2016.
Presented by : S.Rasoulinejad
CRISPR-Cas9 in development and genetic disease
Box Mutations in BRCA1/2 and Rad51 are associated with breast cancer
Non-homologous End Joining (NHEJ)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Mismatch Repair Processing of Iododeoxyuridine
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Xiaoyu Chen, Manuel A.F.V. Gonçalves  iScience 
Figure 2 Use of CRISPR/Cas9 for genome editing
Figure 3 Endogenous repair of double-strand DNA breaks
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
Origin of Chromosomal Translocations in Lymphoid Cancer
Take care of your chromosomes lest cancer take care of you
Gaelen T. Hess, Josh Tycko, David Yao, Michael C. Bassik 
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Luther Davis, Nancy Maizels  Cell Reports 
Molecular Therapy - Nucleic Acids
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
CRISPR genome-editing: A medical revolution
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Volume 154, Issue 6, Pages (September 2013)
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Do DNA Double-Strand Breaks Drive Aging?
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
(A) Poly(ADP-ribosyl)ation often referred to as PARylation is a post-translational protein modification catalyzed by poly(ADP-ribose) polymerases [PARPs].
DNA DAMAGE AND REPAIR BY NIKAM C.D., ASSISTANT PROFESSOR,
VDJ Recombination Cell Volume 94, Issue 4, Pages (August 1998)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
The Fuss about Mus81  James E Haber, Wolf-Dietrich Heyer  Cell 
M.Joan Curcio, Marlene Belfort  Cell 
CRISPR-Mediated Base Editing without DNA Double-Strand Breaks
Figure 1 Chronic inflammation and DNA damage in people with SLE
Volume 20, Issue 12, Pages (September 2017)
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Endogenous DNA Damage as a Source of Genomic Instability in Cancer
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Gene editing: modifying a gene that was already there
Recombination: Holliday Junction Resolution and Crossover Formation
For MutY, It's All about the OG
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
CRISPR/Cas9: Transcending the Reality of Genome Editing
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
(B) HDR assay (6nt) (D) HDR assay (1nt)
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
CRISPR Craze to Transform Cardiac Biology
Fig. 1 RNA and DNA editing activity of each TadA monomer in ABEmax.
Presentation transcript:

Presented by: Oyeyemi Ajayi, Prashant Kuntala, and Colin Kruse

CRISPR/CAS 9 SYSTEM In response to DSB, two DNA repair pathways: NHEJ and HDR are initiated. HDR competes with NHEJ during the resolution of DSBs. Current approach induces Indels from cellular response to dsDNA breaks

This new approach enables the direct, irreversible conversion of one target DNA base into another in a programmable manner, without requiring dsDNA backbone cleavage or a donor template.

A SIMPLISTIC BROAD OVERVIEW OF A NEW APPROACH TO BASE EDITING

Of Base Editors ( three Generations ) Protein Engineering Of Base Editors ( three Generations )

Base Editor – generation 1 Catalytically dead Cas9 (dCas9) fused with rAPOBEC1 (Cytidine deaminase enzyme) to the N-terminus. Inactive nuclease activity (Asp10Ala mutation, His840Ala) Programmable conversion of C to U in DNA. Activity window is approx. 3 to 6 nt In vitro efficiency : 50 to 80% C to U conversion of substrate strands

Context dependence of BE1 BE1 activity preference APOBEC1 prefer substrates with TC or CC TC > CC > AC > GC Max editing efficiency at position 7

Base Editor – generation 1 Catalytically dead Cas9 (dCas9) fused with rAPOBEC1 (Cytidine deaminase enzyme) to the N-terminus. Inactive nuclease activity (Asp10Ala and His840Ala mutations) Programmable conversion of C to U in DNA. Activity window is approx. 3 to 6 nt In vitro efficiency : 50 to 80% C to U conversion of substrate strands But efficiency of C to T editing in Human cells was about 0.8 to 7.7% of total DNA.

Base Editor- generation 2 Hypothesis: Base excision repair (BER) reverts U:G to C:G pair BE2 Uracil DNA glycosylase inhibitor (UGI) fused to the C–terminus of BE1. Increased efficiency in human cells by 3-fold, 20% of total DNA sequences. Indel formation rates <= 0.1% in both BE1 and BE2

Base Editor – generation 3 To augment the base editing efficiency – manipulate cellular DNA repair further. Hypothesis: By nicking the unedited strand, MMR will preferentially repair the unedited strand (G to A) BE3 Restored the catalytic His residue in Cas9 (BE2) that nicks the non- edited strand, containing a G opposite of edited U .

Outcome of BE3 Nicking the non-edited strand augmented base editing efficiency in human cells 2-6 fold relative to BE2, resulting in up to 37% of total DNA sequences containing the targeted C to T.

The Pros and Cons of BE3

BE3-Mediated Correction of Disease-Relevant Mutations Komor et al. set out to correct the two potent missense mutations that could be corrected by C to T (or G to A) base editing p53 Tyr163Cys mutation: cancer associated. APOE4, Cys158Arg mutation: potent Alzheimer's risk factor

BE3-Mediated Induced Base Correction

The Potential of Base Editing

Questions?